|
90
|
301
|
8ov1A |
Sars-cov-2 nsp10-16 methyltransferase in complex with adp |
|
89
|
301
|
8ov4A |
Sars-cov-2 nsp10-16 methyltransferase in complex with toyocamycin |
|
92
|
301
|
8ov2A |
Sars-cov-2 nsp10-16 methyltransferase in complex with sangivamycin |
|
618
|
1721
|
8bcbB |
Human brr2 helicase region in complex with c-tail deleted jab1 and compound 34 |
|
25
|
116
|
8ov1B |
Sars-cov-2 nsp10-16 methyltransferase in complex with adp |
|
27
|
115
|
8ot0B |
Sars-cov-2 nsp10-16 methyltransferase in complex with mta and glycine |
|
191
|
859
|
8ch6N |
Structure of a late-stage activated spliceosome (baqr) arrested with a dominant-negative aquarius mutant (state b complex). |
|
27
|
114
|
8ov2B |
Sars-cov-2 nsp10-16 methyltransferase in complex with sangivamycin |
|
96
|
301
|
8ot0A |
Sars-cov-2 nsp10-16 methyltransferase in complex with mta and glycine |
|
26
|
115
|
8ov3B |
Sars-cov-2 nsp10-16 methyltransferase in complex with 5-iodotubercidin |
|
25
|
116
|
8ov4B |
Sars-cov-2 nsp10-16 methyltransferase in complex with toyocamycin |
|
604
|
1719
|
8bceB |
Human brr2 helicase region in complex with c-tail deleted jab1 and compound 76 |
|
88
|
300
|
8ov3A |
Sars-cov-2 nsp10-16 methyltransferase in complex with 5-iodotubercidin |
|
606
|
1725
|
8bccB |
Human brr2 helicase region in complex with c-tail deleted jab1 and compound 39 |
|
80
|
301
|
8okkA |
Crystal structure of f2f-2020184-00x bound to the main protease (3clpro/mpro) of sars-cov-2. |
|
24
|
116
|
8otoB |
Sars-cov-2 nsp10-16 methyltransferase in complex with amp |
|
78
|
301
|
8okmA |
Crystal structure of f2f-2020197-00x bound to the main protease (3clpro/mpro) of sars-cov-2. |
|
90
|
301
|
8otoA |
Sars-cov-2 nsp10-16 methyltransferase in complex with amp |
|
606
|
1724
|
8bc8B |
Human brr2 helicase region in complex with c-tail deleted jab1 and compound 18 |
|
77
|
301
|
8oklA |
Crystal structure of f2f-2020185-01x bound to the main protease (3clpro/mpro) of sars-cov-2. |
|
81
|
301
|
8oknA |
Crystal structure of f2f-2020198-00x bound to the main protease (3clpro/mpro) of sars-cov-2. |
|
589
|
1724
|
8bcaB |
Human brr2 helicase region in complex with c-tail deleted jab1 and compound 26 |
|
92
|
306
|
8dklA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
86
|
306
|
8ej7A |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
81
|
306
|
8dkhA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
92
|
306
|
8dkkA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
81
|
306
|
8dmnA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
87
|
592
|
7vpxE |
The cryo-em structure of the human pre-a complex |
|
81
|
306
|
8djjA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
76
|
306
|
8eirA |
Sars-cov-2 polyprotein substrate regulates the stepwise mpro cleavage reaction |
|
79
|
306
|
8ej9A |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
59
|
305
|
8ekeA |
Cryo-em structure of sars cov-2 mpro wt protease |
|
74
|
306
|
8dkzA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
88
|
304
|
5smlA |
Pandda analysis group deposition of sars-cov-2 main protease ligands identified from single sequence-guideddeep generative framework -- crystal structure of sars-cov-2 main protease in complex with z68337194 (mpro-ibm0045) |
|
90
|
304
|
5smnA |
Pandda analysis group deposition of sars-cov-2 main protease ligands identified from single sequence-guideddeep generative framework -- crystal structure of sars-cov-2 main protease in complex with z1365651030 (mpro-ibm0078) |
|
87
|
301
|
8hefA |
The crystal structure of deuterated s-217622 (ensitrelvir) bound to the main protease (3clpro/mpro) of sars-cov-2 |
|
91
|
304
|
5smmA |
Pandda analysis group deposition of sars-cov-2 main protease ligands identified from single sequence-guideddeep generative framework -- crystal structure of sars-cov-2 main protease in complex with z1633315555 (mpro-ibm0058) |
|
203
|
618
|
7ziuA |
Crystal structure of ntaya virus ns5 polymerase domain |
|
93
|
448
|
8e5tp |
Yeast co-transcriptional noc1-noc2 rnp assembly checkpoint intermediate |
|
122
|
382
|
7znjA |
Structure of an alyref-exon junction complex hexamer |
|
86
|
306
|
7sh9A |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi86 |
|
87
|
306
|
7sh8A |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi88 |
|
82
|
306
|
7sh7A |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi87 |
|
87
|
303
|
8dzbA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with inhibitor 11 |
|
89
|
311
|
8euaA |
Structure of sars-cov2 plpro bound to a covalent inhibitor |
|
85
|
303
|
8dzcA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with inhibitor 17 |
|
87
|
303
|
8dsuA |
Crystal structure of sars cov-2 mpro with pfizer intravenous inhibitor pf-00835231 |
|
85
|
302
|
8e7nA |
Crystal structure of beluga whale gammacoronavirus sw1 mpro with gc-376 captured in two conformational states |
|
22
|
162
|
8dk6E |
Structure of hepatitis c virus envelope n-terminal truncated glycoprotein 2 (e2) (residues 456-713) from j6 genotype |
|
75
|
304
|
8e7cA |
Crystal structure of porcine deltacoronavirus (hku-15) mpro with pfizer intravenous inhibitor pf-00835231 |
